| Effectiveness of needle and syringe Programmes in people who inject drugs–An overview of systematic reviews RM Fernandes, M Cary, G Duarte, G Jesus, J Alarcão, C Torre, S Costa, ... BMC public health 17, 1-15, 2017 | 249 | 2017 |
| The association between polypharmacy and adverse health consequences in elderly type 2 diabetes mellitus patients; a systematic review and meta-analysis ALM Labib, AP Martins, JF Raposo, C Torre Diabetes Research and Clinical Practice 155, 107804, 2019 | 74 | 2019 |
| Polypharmacy, potentially serious clinically relevant drug‐drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life L AL‐Musawe, C Torre, JP Guerreiro, AT Rodrigues, JF Raposo, ... Pharmacology research & perspectives 8 (4), e00621, 2020 | 34 | 2020 |
| Factors associated with underreporting of adverse drug reactions by health care professionals: a systematic review update P García-Abeijon, C Costa, M Taracido, MT Herdeiro, C Torre, A Figueiras Drug Safety 46 (7), 625-636, 2023 | 25 | 2023 |
| Patterns of glucose lowering drugs utilization in Portugal and in the Netherlands. Trends over time C Torre, J Guerreiro, S de Oliveira Martins, JF Raposo, AP Martins, ... primary care diabetes 9 (6), 482-489, 2015 | 25 | 2015 |
| Syringe exchange in community pharmacies—The Portuguese experience C Torre, R Lucas, H Barros International Journal of Drug Policy 21 (6), 514-517, 2010 | 21 | 2010 |
| Treatment Advances in Sepsis and Septic Shock: Modulating Pro-and Anti-Inflammatory Mechanisms A Marques, C Torre, R Pinto, B Sepodes, J Rocha Journal of Clinical Medicine 12 (8), 2892, 2023 | 20 | 2023 |
| A Review of Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union between 2017 and 2020 MM Teixeira, FC Borges, PS Ferreira, J Rocha, B Sepodes, CM Torre Frontiers in Medicine, 2385, 2022 | 20 | 2022 |
| Burnout in the pharmaceutical activity: the impact of COVID-19 PM Santos, CR Silva, D Costa, C Torre Frontiers in Psychiatry 12, 771462, 2022 | 18 | 2022 |
| A review of the continuous professional development system for pharmacists JPB Batista, C Torre, JM Sousa Lobo, B Sepodes Human resources for health 20 (1), 3, 2022 | 17 | 2022 |
| Overview of pharmacoepidemiological databases in the assessment of medicines under real-life conditions C Torre, AP Martins Epidemiology—Current Perspectives on Research and Practice. Croatia: In …, 2012 | 16 | 2012 |
| Factors associated with underreporting of adverse drug reactions by patients: a systematic review C Costa, P Abeijon, DA Rodrigues, A Figueiras, MT Herdeiro, C Torre International Journal of Clinical Pharmacy 45 (6), 1349-1358, 2023 | 13 | 2023 |
| Real-world prevalence of mild to moderate hypoglycemic episodes in type 2 diabetes in Portugal: results from the HIPOS-PHARMA study C Torre, JP Guerreiro, S Romano, A Miranda, P Longo, S Alão, ... Primary Care Diabetes 12 (6), 537-546, 2018 | 11 | 2018 |
| Health-related quality of life in adults with type 2 diabetes mellitus starting with new glucose lowering drugs: An inception cohort study C Torre, J Guerreiro, P Longo, JF Raposo, H Leufkens, AP Martins Primary Care Diabetes 13 (3), 221-232, 2019 | 10 | 2019 |
| Serviço de vacinação nas farmácias portuguesas IP Jacinto, S Costa, MR Horta, Z Mendes, C Torre, JP Guerreiro, ... Revista Portuguesa De Farmacoterapia 7 (3), 13-19, 2015 | 10 | 2015 |
| Drug-drug interactions and inappropriate medicines impact on glycemic control and kidney function in older adults with diabetes-attending specialty care institution L Al-Musawe, C Torre, JP Guerreiro, AT Rodrigues, JF Raposo, ... European Journal of Clinical Pharmacology 77, 1397-1407, 2021 | 9 | 2021 |
| Use of generic and essential medicines for prevention and treatment of cardiovascular diseases in Portugal H Gama, C Torre, JP Guerreiro, A Azevedo, S Costa, N Lunet BMC Health Services Research 17, 1-11, 2017 | 8 | 2017 |
| Inclusion of functional measures and frailty in the development and evaluation of medicines for older adults M Denkinger, W Knol, A Cherubini, A Simonds, C Lionis, D Lacombe, ... The Lancet Healthy Longevity 4 (12), e724-e729, 2023 | 7 | 2023 |
| Effect of different methods for estimating persistence and adherence to new glucose-lowering drugs: results of an observational, inception cohort study in Portugal C Torre, J Guerreiro, P Longo, JF Raposo, H Leufkens, AP Martins Patient preference and adherence, 1471-1482, 2018 | 6 | 2018 |
| Syringe exchange programmes in the context of harm reduction C Torre ArquiMed-Edições Científicas AEFMUP, 2009 | 6 | 2009 |
